TotalMarketCap

Cadrenal Therapeutics

CVKDNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.567 M

$1.00 -5.67%

Close of 6 Nov 2026

As of 6 Nov 2026, Cadrenal Therapeutics (CVKD) has a market capitalization of $3.57M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$13.2M

Loss-making

Shares outstanding

3,567,592

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #461Dermata TherapeuticsDRMA$3.82M
  2. #462RedHill BiopharmaRDHL$3.73M
  3. #463Cadrenal TherapeuticsCVKD$3.57M
  4. #464GRI BioGRI$3.45M
  5. #465Medicus PharmaMDCX$3.45M

What if Cadrenal Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$7,914,828

Per share 7,915,619× higher

Bitcoin $1.53T

$428,257.54

Per share 428,300× higher

Apple $5.02T

$1,405,930

Per share 1,406,070× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Cadrenal Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.